
Jack Wilson critiques a recent Danish longitudinal study published in JAMA Psychiatry, which suggests that cannabis use disorder is independently associated with bipolar disorder and unipolar depression.
[read the full story...]Jack Wilson critiques a recent Danish longitudinal study published in JAMA Psychiatry, which suggests that cannabis use disorder is independently associated with bipolar disorder and unipolar depression.
[read the full story...]In their debut blog, Grace Williamson and Daniel Leightley review a US study on chronic pain, cannabis legalisation, and cannabis use disorder in US veterans.
[read the full story...]Sally Turner reviews a recent study exploring cannabis use in college, which provides useful evidence relating to how universities could promote a sense of community, belonging and support to students who use cannabis.
[read the full story...]In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
[read the full story...]Ian Hamilton summarises a recent study exploring whether psychotic-like experiences are related to the discontinuation of cannabis consumption in young adults.
[read the full story...]Ian Hamilton looks at the new International Cannabis Toolkit (iCannToolkit) and considers why it’s so important that we have an internationally agreed and standardised measure for cannabis use.
[read the full story...]This review investigating the relationship between drug use (methamphetamines, heroin, opiates, cocaine, cannabis and crack) and oral health includes 10 observational studies showing a higher risk of caries.
[read the full story...]Ian Hamilton shares his thoughts on the new Drug Use series published yesterday in The Lancet: The global drug problem – change but not progression.
[read the full story...]Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.
[read the full story...]Ian Hamilton looks at a Swedish 42-year follow-up study, which looks at the impact that psychiatric comorbidity can have on premature death in a cohort of patients with substance use disorders.
[read the full story...]